We are delighted to announce that Oximio Israel has been successfully awarded yet another import license for Compassionate use program in January 2023.

“Compassionate use” allows for a patient outside of clinical trials with a serious or life-threatening disease to gain access to an investigational medical product including drug, biologic, or medical device when no alternative therapy options are available.

Compassionate use, patient centricity

There are three scenarios when a patient can get an access to the unlicensed medication:

  1. Compassionate use program: the patient has never taken part in a clinical trial.
  2. Post-trial access: the patient has completed or dropped out of the clinical trial.
  3. Unlicensed supply: when the unregistered medication can be imported for an individual patient.

Oximio Israel has been successfully arranging licences for the above programmes since 2014.

At Oximio we strive to put the patient first and to find solutions to better our patient-centric services to compassionately achieve the best experience and outcome for the person and the family.

About Oximio

Oximio is a clinical trial services provider contributing to research to find effective treatment and cures for all living beings globally. Oximio works hard to convert the ever-changing face of investigational medical products into new medicines, bringing over 17 years of service excellence to the clinical trial industry. The company directly connects to several patient communities of over 500 million people by being present in the United Kingdom, Eastern Europe, Western Asia, and Africa. Oximio’s large and loyal client base ranges from start-ups to major international organizations, pharmaceutical and R&D companies. Oximio is in the front line of servicing clinical trials with own warehouses and, through licensed partner sites, offers an end-to-end cold-chain control system in all premises. By combining its’ ‘best-in-class’ depot network with a highly experienced and qualified workforce, Oximio is thoroughly conversant with both global and local procedures for clinical trials, ensuring the highest standards of operation. Oximio has the following capabilities: supply planning and consulting, comparator sourcing, patient centricity, advanced therapy solutions, import & export regulations, relabelling, warehousing, distribution and courier services, return & destruction.

Contact us